![Action: Sales and gross profit margin for May revealed](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/action-sales-and-gross-profit-margin-for-may-revealed.jpeg&w=215)
Author's articles
![Action: Sales and gross profit margin for May revealed](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/action-sales-and-gross-profit-margin-for-may-revealed.jpeg&w=215)
![1Q'24 Financial Review: Revenue Decline Overshadows Cost Management Efforts](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/1q-24-financial-review-revenue-decline-overshadows-cost-management-efforts.jpeg&w=215)
1Q'24 Financial Review: Revenue Decline Overshadows Cost Management Efforts
![Robust 1Q24 Performance: Strong Revenue Growth and Improved Operational Efficiency](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/robust-1q24-performance-strong-revenue-growth-and-improved-operational-efficiency.jpeg&w=215)
Robust 1Q24 Performance: Strong Revenue Growth and Improved Operational Efficiency
![DM BOŚ SA Research Report Excerpt: Strong 1Q24 Performance Driven by Diagnostic Segment Growth](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/dm-bos-sa-research-report-excerpt-strong-1q24-performance-driven-by-diagnostic-segment-growth.jpeg&w=215)
DM BOŚ SA Research Report Excerpt: Strong 1Q24 Performance Driven by Diagnostic Segment Growth
![Transitional period We reiterate a BUY rating, but lowered our 12-month price target to PLN 3.7](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/transitional-period-we-reiterate-a-buy-rating-but-lowered-our-12-month-price-target-to-pln-3-7.jpeg&w=215)
Transitional period We reiterate a BUY rating, but lowered our 12-month price target to PLN 3.7
![1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/1q-24-ebitda-of-pln-14-8mn-i-e-3-above-our-forecasts.jpeg&w=215)
1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts
![1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/1q-24-ebitda-of-pln-14-8mn-i-e-3-above-our-forecasts-31-05-2024.jpeg&w=215)
1Q’24 EBITDA of PLN 14.8mn i.e. 3% above our forecasts - 31.05.2024
![Financial Highlights and Operational Insights: 1Q24 Performance Analysis](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/financial-highlights-and-operational-insights-1q24-performance-analysis.jpeg&w=215)
Financial Highlights and Operational Insights: 1Q24 Performance Analysis
![Sunex: Upgrading to BUY Despite Near-Term Weakness Expectations](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/sunex-upgrading-to-buy-despite-near-term-weakness-expectations.jpeg&w=215)
Sunex: Upgrading to BUY Despite Near-Term Weakness Expectations
![Sunex: 4Q23 Results Review and 1Q24 Preview Amid Sales Decline](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/sunex-4q23-results-review-and-1q24-preview-amid-sales-decline.jpeg&w=215)
Sunex: 4Q23 Results Review and 1Q24 Preview Amid Sales Decline
![Steady Outlook Despite Market Challenges](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/steady-outlook-despite-market-challenges.jpeg&w=215)
Steady Outlook Despite Market Challenges
![Enhanced Dividend Policy: Semi-Annual Dividends to Foster Investor Confidence](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/enhanced-dividend-policy-semi-annual-dividends-to-foster-investor-confidence.jpeg&w=215)
Enhanced Dividend Policy: Semi-Annual Dividends to Foster Investor Confidence
![Strategic Expansion: IMS's Ambitious Plans for 2024](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/strategic-expansion-ims-s-ambitious-plans-for-2024.jpeg&w=215)
Strategic Expansion: IMS's Ambitious Plans for 2024
![Navigating Challenges: Analysis and Outlook for Artifex's "Unsolved" in 2024](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/navigating-challenges-analysis-and-outlook-for-artifex-s-unsolved-in-2024.jpeg&w=215)
Navigating Challenges: Analysis and Outlook for Artifex's "Unsolved" in 2024
![Driving Growth: DataWalk's 1Q24 Preliminary Results and Investor Insights](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/driving-growth-datawalk-s-1q24-preliminary-results-and-investor-insights.jpeg&w=215)
Driving Growth: DataWalk's 1Q24 Preliminary Results and Investor Insights
![Rebuilding Momentum: Analyzing Company Backlog and Future Prospects](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/rebuilding-momentum-analyzing-company-backlog-and-future-prospects.jpeg&w=215)
Rebuilding Momentum: Analyzing Company Backlog and Future Prospects
![Navigating Challenges: Relpol's Journey Amidst Economic Shifts](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/navigating-challenges-relpol-s-journey-amidst-economic-shifts.jpeg&w=215)
Navigating Challenges: Relpol's Journey Amidst Economic Shifts
![Navigating Short-Term Challenges: Company's Backlog and Prospects](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/navigating-short-term-challenges-company-s-backlog-and-prospects.jpeg&w=215)
Navigating Short-Term Challenges: Company's Backlog and Prospects
![Miraculum's 1Q24 Results: Strong EBITDA Growth and Improved Margins Despite Revenue Decline](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/miraculum-s-1q24-results-strong-ebitda-growth-and-improved-margins-despite-revenue-decline.jpeg&w=215)
Miraculum's 1Q24 Results: Strong EBITDA Growth and Improved Margins Despite Revenue Decline
![Bowim Releases Preliminary 1Q24 Financial Results: Revenue Declines but Net Profit Increases](https://admin.es-fxmag-com.usermd.net/api/image?url=media/pics/bowim-releases-preliminary-1q24-financial-results-revenue-declines-but-net-profit-increases.jpeg&w=215)